Navigation Links
Renal Research Institute Announces Scientific Presentations at the American Society of Nephrology Kidney Week
Date:10/31/2011

NEW YORK, Oct. 31, 2011 /PRNewswire/ -- At the American Society of Nephrology's (ASN) Kidney Week 2011, Renal Research Institute, LLC (RRI) is presenting research results from studies involving dialysis treatment, patient care and outcomes. RRI is dedicated to advancing therapy options for dialysis patients to provide the highest caliber of care based on advanced clinical technology. ASN's Kidney Week 2011 takes place Nov. 8-13 in Philadelphia, PA. It is the largest scientific gathering of kidney disease experts worldwide and organizers expect more than 13,000 attendees among them more than 10,000 scientists and clinicians.  

A selection of RRI research being presented this year includes:

  • Declining Interdialytic Weight Gain in Chronic HD Patients: An Ominous Sign? Results of an International Study. Adrian Marcos Guinsburg, MD, Cristina Marelli, MD, Adam Tashman, Michael Etter, MD, PhD, Daniele Marcelli, MD, Gero D. von Gersdorff, MD, Mathias Schaller, Yuedong Wang, PhD, Nathan W. Levin, MD, Peter Kotanko, MD and Len A. Usvyat.

  • Lower Dialysate Na+ Impacts Weight Gain And Fluid Overload Hospitalizations. Eduardo K. Lacson, MD, John Rogus, PhD, Peter Kotanko, MD, Nathan W. Levin, MD and Raymond M. Hakim, MD, PhD

  • Trends in Serum Na+ Levels Relate to Mortality in Incident HD Patients. Jochen G. Raimann, MD, Len A. Usvyat, Jeroen Kooman, MD, Frank van der Sande, MD, PhD, Stephan Thijssen, MD, Peter Kotanko, MD, Nathan W. Levin, MD.

  • Independent Validation of a Versatile Citrate Dialysis Model. Stephan Thijssen, MD, Len A. Usvyat, Jeffrey J. Sands, MD, Nathan W. Levin, MD, Peter Kotanko, MD and Jose A. Diaz-Buxo, MD

  • Red Blood Cell Life Span is Associated with Hemoglobin Variability in Chronic Hemodialysis Patients. Yanna Dou, MD, Anja Kruse, MD, Georges Ouellet, MD, Stephan Thijssen, MD, Nathan W. Levin, MD and Peter Kotanko, MD.

RRI will share their newest scientific findings in a total of over two dozen presentations at this year's ASN Kidney Week. Kidney Week 2011, the largest nephrology meeting worldwide, will provide a forum to discuss the latest findings in renal research and engage in educational sessions related to advances in the care of patients with kidney and related disorders. RRI contributes research to ASN each year on kidney disease, its related complications and treatment options, to further the advancement of kidney care quality and patient outcomes.

Founded in 1966, the American Society of Nephrology (ASN) is the world's largest professional society devoted to the study of kidney disease. Comprised of 11,000 physicians and scientists, ASN continues to promote expert patient care, to advance medical research, and to educate the renal community. ASN also informs policymakers about issues of importance to kidney doctors and their patients. ASN funds research, and through its world-renowned meetings and first-class publications, disseminates information and educational tools that empower physicians.

About Renal Research Institute

Formed in early 1997, Renal Research Institute embodies scientific commitment to better kidney care. RRI is a research collaboration between Fresenius Medical Care and New York's Beth Israel Medical Center with a goal to produce measurable improvements in patient outcomes, building on clinical nephrology and evaluating and applying new technology to enhance the quality of patient care. Through its collaborative relationships with dialysis facilities and strong ties to academic research institutions, RRI is able to enhance the spectrum of comprehensive renal services by advancing peritoneal and hemodialysis therapies through clinical research and the application of practice guidelines and new technology. This synergy with university partners, industry, and dialysis clinics is the first of its kind in the field of kidney disease. For more information, please visit www.renalresearch.com.


'/>"/>
SOURCE Renal Research Institute, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. PLC Systems RenalGuard® to be Featured in Chronic Kidney Disease and Contrast Nephropathy Session at TCT 2011
2. PLC Systems Receives FDA Approval to Commence Pivotal Study of RenalGuard in the U.S.
3. PLC Systems Signs ACIST Medical Systems, to Distribute RenalGuard® in France and Germany
4. PLC Receives Two Additional U.S. Patents and First Japanese Patent For Its RenalGuard® Technology
5. Hospira Announces Positive Results From Phase I U.S. Clinical Trial of Biosimilar Erythropoietin in Renal Patients
6. REMEDIAL II Trial of PLCs RenalGuard® Article Published in Circulation
7. Galil Medical Announces Reimbursement for Small Renal Cancer Cryoablation in Japan
8. B. Braun Renal Therapies Division Announces Availability of Advanced Apheresis Therapy System
9. JHP Pharmaceuticals Launches New Multipack Presentations of Adrenalin®, Coly-Mycin® M and Pitocin®
10. PLC Ramps Up for U.S. Clinical Trial of RenalGuard®
11. Argos Therapeutics Arcelis™ Immunotherapy for the Treatment of Renal Cell Carcinoma (RCC) in Combination With Sunitinib Demonstrates Strong Immunologic Response That Correlates to Improved Clinical Outcomes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/16/2017)... LOVELAND, Colo. , Jan. 16, 2017  Northern ... , is bringing advanced laser treatments to ... specialty clinic focuses solely on the removal of unwanted ... and fading for tattoo cover-ups. "Tattoos are ... out the way we hope they would," said ...
(Date:1/16/2017)... January 16, 2017 ... Product Type (Methyl, Ethyl, Hydroxyethyl, Hydroxypropyl, Carboxymethyl ... Beverages, Surface Coatings & Paints), Region - ... the market was valued at USD 4.51 ... reach USD 6.41 Billion by 2021, at ...
(Date:1/16/2017)... -- Transparency Market Research states that the leading ... a huge share of 43% in 2015. Apple Inc., F.Hoffmann-La ... overall market, grabbing the undivided attention of buyers with their ... strong product portfolio is expected to keep these companies in ... ...
Breaking Medicine Technology:
(Date:1/16/2017)... ... January 16, 2017 , ... ... Chief Executive Officer of the medical device company, effective immediately. , “This is ... “Kevin has a strong track record in medical device market development and ...
(Date:1/15/2017)... ... , ... Whole Health Supply, LLC is announcing the release of an updated version of their ... , The 2017 edition has wide jaws that will accommodate nails up to 4mm ... as diabetics. This handle is reinforced for extra strength when pressing down on dense nails ...
(Date:1/15/2017)... ... , ... Wondering where to go this Valentine's Day? Well, there is a ... romantic, lobster feast in the comfort of your own home. Lobster Gram is introducing ... be featured until February 15th, 2017. , Romantic Dinner one is Lobster Gram's ...
(Date:1/14/2017)... ... January 13, 2017 , ... ... Soul, incorporating a magnesium-rich Mediterranean diet may lower the risk of type 2 ... notes that the many health and wellness benefits linked to a Mediterranean diet ...
(Date:1/13/2017)... ... ... The 18th European Congress: Perspectives in Lung Cancer will be held in Madrid ... expertly designed to meet the educational needs of European oncology clinicians and researchers who ... Giorgio V. Scagliotti, Professor of Oncology at the University of Torino, and organized by ...
Breaking Medicine News(10 mins):